Report cover image

South Korea Generics Market Summary, Competitive Analysis and Forecast, 2017-2026

Publisher MarketLine
Published Jul 06, 2022
Length 46 Pages
SKU # MTLN17380894

Description

South Korea Generics Market Summary, Competitive Analysis and Forecast, 2017-2026

Summary

Generics in South Korea industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value and volume 2017-21, and forecast to 2026). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.

Key Highlights
  • For the purposes of this profile, a generic drug is defined as a copy of an ethical (prescription) drug formerly protected by patents that have now expired. Both unbranded generics and all branded generics are included. However, off-patent drugs that continue to be offered by the original manufacturer under the original name, and which form part of the 'generic-eligible' market, are not included.
  • The South Korean generics market had total revenues of $5.4 billion in 2021, representing a compound annual growth rate (CAGR) of 3.7% between 2016 and 2021.
  • Market consumption volume increased with a CAGR of 2.9% between 2016 and 2021, to reach a total of 79.6 % in 2021.
  • Over the past five years, the South Korean market recorded growth of 4.2%. Growth in the market has been driven by demographic trends as South Korea has one of the fastest aging populations.
Scope
  • Save time carrying out entry-level research by identifying the size, growth, major segments, and leading players in the generics market in South Korea
  • Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the generics market in South Korea
  • Leading company profiles reveal details of key generics market players’ global operations and financial performance
  • Add weight to presentations and pitches by understanding the future growth prospects of the South Korea generics market with five year forecasts by both value and volume
Reasons to Buy
  • What was the size of the South Korea generics market by value in 2021?
  • What will be the size of the South Korea generics market in 2026?
  • What factors are affecting the strength of competition in the South Korea generics market?
  • How has the market performed over the last five years?
  • Who are the top competitors in South Korea's generics market?

Table of Contents

46 Pages
1 Executive Summary
1.1. Market value
1.2. Market value forecast
1.3. Market volume
1.4. Market volume forecast
1.5. Geography segmentation
1.6. Market rivalry
1.7. Competitive Landscape
2 Market Overview
2.1. Market definition
2.2. Market analysis
3 Market Data
3.1. Market value
3.2. Market volume
4 Market Segmentation
4.1. Geography segmentation
5 Market Outlook
5.1. Market value forecast
5.2. Market volume forecast
6 Five Forces Analysis
6.1. Summary
6.2. Buyer power
6.3. Supplier power
6.4. New entrants
6.5. Threat of substitutes
6.6. Degree of rivalry
7 Competitive Landscape
7.1. Who are the leading players?
7.2. What are the strengths/weaknesses of the leading players?
7.3. Has there been any significant recent M&A activity?
7.4. How did the COVID-19 pandemic impact leading players?
8 Company Profiles
8.1. Pfizer Inc.
8.2. Teva Pharmaceutical Industries Limited
8.3. Yuhan Corp
8.4. Viatris Inc.
9 Macroeconomic Indicators
9.1. Country data
10 Appendix
10.1. Methodology
10.2. Industry associations
10.3. Related MarketLine research
10.4. About MarketLine
List of Tables
Table 1: South Korea generics market value: $ million, 2016-21
Table 2: South Korea generics market volume: %, 2016-21
Table 3: South Korea generics market geography segmentation: $ million, 2021
Table 4: South Korea generics market value forecast: $ million, 2021-26
Table 5: South Korea generics market volume forecast: %, 2021-26
Table 6: Pfizer Inc.: key facts
Table 7: Pfizer Inc.: Annual Financial Ratios
Table 8: Pfizer Inc.: Key Employees
Table 9: Pfizer Inc.: Key Employees Continued
Table 10: Teva Pharmaceutical Industries Limited: key facts
Table 11: Teva Pharmaceutical Industries Limited: Annual Financial Ratios
Table 12: Teva Pharmaceutical Industries Limited: Key Employees
Table 13: Yuhan Corp: key facts
Table 14: Yuhan Corp: Annual Financial Ratios
Table 15: Yuhan Corp: Key Employees
Table 16: Viatris Inc.: key facts
Table 17: Viatris Inc.: Annual Financial Ratios
Table 18: Viatris Inc.: Key Employees
Table 19: Viatris Inc.: Key Employees Continued
Table 20: South Korea size of population (million), 2017-21
Table 21: South Korea gdp (constant 2005 prices, $ billion), 2017-21
Table 22: South Korea gdp (current prices, $ billion), 2017-21
Table 23: South Korea inflation, 2017-21
Table 24: South Korea consumer price index (absolute), 2017-21
Table 25: South Korea exchange rate, 2017-21
List of Figures
Figure 1: South Korea generics market value: $ million, 2016-21
Figure 2: South Korea generics market volume: %, 2016-21
Figure 3: South Korea generics market geography segmentation: % share, by value, 2021
Figure 4: South Korea generics market value forecast: $ million, 2021-26
Figure 5: South Korea generics market volume forecast: %, 2021-26
Figure 6: Forces driving competition in the generics market in South Korea, 2021
Figure 7: Drivers of buyer power in the generics market in South Korea, 2021
Figure 8: Drivers of supplier power in the generics market in South Korea, 2021
Figure 9: Factors influencing the likelihood of new entrants in the generics market in South Korea, 2021
Figure 10: Factors influencing the threat of substitutes in the generics market in South Korea, 2021
Figure 11: Drivers of degree of rivalry in the generics market in South Korea, 2021

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us